The Emerging Role of microRNAs in Polyglutamine Diseases

被引:24
作者
Dong, Xiaoyu [1 ]
Cong, Shuyan [1 ]
机构
[1] China Med Univ, Dept Neurol, Shengjing Hosp, Shenyang, Liaoning, Peoples R China
来源
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2019年 / 12卷
基金
中国国家自然科学基金;
关键词
microRNAs; polyglutamine diseases; biomarker; neurodegeneration; therapy; HUNTINGTONS-DISEASE; CELLULAR-MODEL; GENE; ATAXIA; MUTANT; DYSREGULATION; SUPPRESSION; EXPRESSION; BIOMARKERS; NEUROGENESIS;
D O I
10.3389/fnmol.2019.00156
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
MicroRNAs (miRNAs) are small non-coding molecules that regulate a large amount of post-transcriptional repressor genes by recognizing semi-complementary target sequences that are normally located in the 3' UTR of the mRNA. Altered expression of miRNA has been related to several pathological processes, including polyglutamine (Poly Q) diseases. Specific expression patterns in the circulating fluids and brain parenchyma have been speculated as potential biomarkers for Poly Q disease diagnosis and prognosis. Several miRNAs have been consistently identified in diseases including Huntington's disease (HD) and spinocerebellar ataxia (SCA). In our review, we describe the emerging role of miRNAs in Poly Q diseases and provide an overview on general miRNA biology, implications in pathophysiology, and their potential roles as future biomarkers and applications for therapy.
引用
收藏
页数:11
相关论文
共 108 条
  • [1] Machado-Joseph Disease: from first descriptions to new perspectives
    Bettencourt, Conceicao
    Lima, Manuela
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
  • [2] MicroRNA-132,-134, and -138: a microRNA troika rules in neuronal dendrites
    Bicker, Silvia
    Lackinger, Martin
    Weiss, Kerstin
    Schratt, Gerhard
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2014, 71 (20) : 3987 - 4005
  • [3] Borel Florie, 2011, J RNAi Gene Silencing, V7, P434
  • [4] Wide Profiling of Circulating MicroRNAs in Spinocerebellar Ataxia Type 7
    Borgonio-Cuadra, Veronica M.
    Valdez-Vargas, Claudia
    Romero-Cordoba, Sandra
    Hidalgo-Miranda, Alfredo
    Tapia-Guerrero, Yessica
    Cerecedo-Zapata, Cesar M.
    Hernandez-Hernandez, Oscar
    Cisneros, Bulmaro
    Magana, Jonathan J.
    [J]. MOLECULAR NEUROBIOLOGY, 2019, 56 (09) : 6106 - 6120
  • [5] Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
    Boudreau, Ryan L.
    McBride, Jodi L.
    Martins, Ines
    Shen, Shihao
    Xing, Yi
    Carter, Barrie J.
    Davidson, Beverly L.
    [J]. MOLECULAR THERAPY, 2009, 17 (06) : 1053 - 1063
  • [6] Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease
    Carmona, Vitor
    Cunha-Santos, Janete
    Onofre, Isabel
    Simoes, Ana Teresa
    Vijayakumar, Udaya
    Davidson, Beverly L.
    de Almeida, Luis Pereira
    [J]. MOLECULAR THERAPY, 2017, 25 (04) : 1038 - 1055
  • [7] Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene/Allele-Specific Silencing of Mutant Huntingtin
    Carroll, Jeffrey B.
    Warby, Simon C.
    Southwell, Amber L.
    Doty, Crystal N.
    Greenlee, Sarah
    Skotte, Niels
    Hung, Gene
    Bennett, C. Frank
    Freier, Susan M.
    Hayden, Michael R.
    [J]. MOLECULAR THERAPY, 2011, 19 (12) : 2178 - 2185
  • [8] Down-regulation of miR-9*in the peripheral leukocytes of Huntington's disease patients
    Chang, Kuo-Hsuan
    Wu, Yih-Ru
    Chen, Chiung-Mei
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [9] Developmental Insights Into the Pathology of and Therapeutic Strategies for DM1: Back to the Basics
    Chau, Anthony
    Kalsotra, Auinash
    [J]. DEVELOPMENTAL DYNAMICS, 2015, 244 (03) : 377 - 390
  • [10] The Role of MiR-132 in Regulating Neural Stem Cell Proliferation, Differentiation and Neuronal Maturation
    Chen, Dong
    Hu, Siyuan
    Wu, Zhong
    Liu, Jie
    Li, Shaohua
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (06) : 2319 - 2330